Cardio Diagnostics Holdings Future Growth
Future criteria checks 2/6
Cardio Diagnostics Holdings is forecast to grow earnings and revenue by 32.3% and 201.5% per annum respectively while EPS is expected to grow by 37.8% per annum.
Key information
32.3%
Earnings growth rate
37.8%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 201.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 25 Nov 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 1 | -6 | N/A | -5 | 1 |
| 12/31/2024 | 0 | -8 | N/A | -5 | 1 |
| 9/30/2024 | 0 | -8 | -6 | -5 | N/A |
| 6/30/2024 | 0 | -9 | -6 | -5 | N/A |
| 3/31/2024 | 0 | -12 | -6 | -5 | N/A |
| 12/31/2023 | 0 | -8 | -6 | -6 | N/A |
| 9/30/2023 | 0 | -9 | -7 | -7 | N/A |
| 6/30/2023 | 0 | -9 | -8 | -7 | N/A |
| 3/31/2023 | 0 | -5 | -7 | -7 | N/A |
| 12/31/2022 | 0 | -5 | -5 | -5 | N/A |
| 9/30/2022 | 0 | -2 | -2 | -2 | N/A |
| 6/30/2022 | 0 | -2 | -1 | -1 | N/A |
| 3/31/2022 | 0 | -1 | -1 | -1 | N/A |
| 12/31/2021 | 0 | -1 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CDIO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CDIO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CDIO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CDIO's revenue (201.5% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: CDIO's revenue (201.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CDIO's Return on Equity is forecast to be high in 3 years time